Intra-Cellular Therapies, Inc.
NasdaqGS:ITCI
$ 71.01
+ $2.21 (3.21%)
$ 71.01
+ $2.21 (3.21%)
Precio de cierre: 06/05/2024

ITCI: Alternativas globales de inversión y competidores

Competidores

Simbolo bursátil Precio Pronóstico 1A Pronóstico 2A Cap. Mercado Div Yld Tasa de crecimiento
NYSE:LLY
Eli Lilly and
766.68 -48.51% -27.38% 690,322.8 0.71% 2.63%
NYSE:ABBV
AbbVie
162.73 -21.32% -10.92% 287,359.66 3.79% 7.03%
LSE:AZN
AstraZeneca PLC
120.50 19.51% 42.33% 186,803.32 2.05% 15.98%
NYSE:PFE
Pfizer
28.16 10.25% 40.97% 159,457.16 6.04% -9.31%
NYSE:TEVA
Teva Pharmaceutical Industries
14.06 -37.68% -33.66% 15,924.93 0% -2.6%
NasdaqGS:VTRS
Viatris Inc
11.82 1.95% 12.16% 13,740.18 4.07% -8.55%
CPSE:HLUN A
H. Lundbeck A/S
33.54 96.51% 123.29% 32,856.1 2.09% 32.92%
NasdaqGS:ALKS
Alkermes
24.10 175.95% 200.99% 4,062.11 0% 18.74%
LSE:INDV
Indivior PLC
14.35 -23.61% -1.68% 1,952.43 0% -2.7%
NasdaqGM:VNDA
Vanda Pharmaceuticals
4.84 0% 0% 284.01 0% -8.62%